###begin article-title 0
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
Characterization of the canine CLCN3 gene and evaluation as candidate for late-onset NCL
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clcn3</italic>
###xml 200 204 <span type="species:ncbi:9615">dogs</span>
###xml 326 331 <span type="species:ncbi:9606">human</span>
###xml 349 352 <span type="species:ncbi:9615">dog</span>
###xml 388 393 <span type="species:ncbi:9606">human</span>
###xml 413 417 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
The neuronal ceroid lipofuscinoses (NCL) are a heterogenous group of inherited progressive neurodegenerative diseases in different mammalian species. Tibetan Terrier and Polish Owczarek Nizinny (PON) dogs show rare late-onset NCL variants with autosomal recessive inheritance, which can not be explained by mutations of known human NCL genes. These dog breeds represent animal models for human late-onset NCL. In mice the chloride channel 3 gene (Clcn3) encoding an intracellular chloride channel was described to cause a phenotype similar to NCL.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 186 192 186 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 297 303 297 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 480 486 480 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 342 346 <span type="species:ncbi:9615">dogs</span>
###xml 397 400 <span type="species:ncbi:9615">dog</span>
###xml 443 447 <span type="species:ncbi:9615">dogs</span>
Two full-length cDNA splice variants of the canine CLCN3 gene are reported. The current canine whole genome sequence assembly was used for gene structure analyses and revealed 13 coding CLCN3 exons in 52 kb of genomic sequence. Sequence analysis of the coding exons and flanking intron regions of CLCN3 using six NCL-affected Tibetan terrier dogs and an NCL-affected Polish Owczarek Nizinny (PON) dog, as well as eight healthy Tibetan terrier dogs revealed 13 SNPs. No consistent CLCN3 haplotype was associated with NCL.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 271 274 <span type="species:ncbi:9615">dog</span>
For the examined animals we excluded the complete coding region and adjacent intronic regions of canine CLCN3 to harbor disease-causing mutations. Therefore it seems to be unlikely that a mutation in this gene is responsible for the late-onset NCL phenotype in these two dog breeds.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 908 937 908 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPT1, TPP1, CLN3, CLN5, CLN6 </italic>
###xml 941 945 941 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN8</italic>
###xml 948 949 948 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1101 1102 1101 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1103 1104 1103 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1166 1171 1166 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN8 </italic>
###xml 1175 1180 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN5 </italic>
###xml 1284 1285 1284 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1286 1288 1286 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1479 1484 1479 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTSD </italic>
###xml 1548 1553 1548 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTSD </italic>
###xml 1606 1608 1606 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1621 1626 1621 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTSD </italic>
###xml 1703 1705 1703 1705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1745 1750 1745 1750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clcn3</italic>
###xml 1846 1848 1846 1848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1851 1856 1851 1856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clcn3</italic>
###xml 2118 2124 2118 2124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 107 110 <span type="species:ncbi:9606">man</span>
###xml 112 116 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 152 158 <span type="species:ncbi:9913">cattle</span>
###xml 160 165 <span type="species:ncbi:9940">sheep</span>
###xml 167 171 <span type="species:ncbi:9925">goat</span>
###xml 173 176 <span type="species:ncbi:9685">cat</span>
###xml 190 193 <span type="species:ncbi:9615">dog</span>
###xml 444 450 <span type="species:ncbi:9606">humans</span>
###xml 574 578 <span type="species:ncbi:9615">dogs</span>
###xml 684 688 <span type="species:ncbi:9615">dogs</span>
###xml 731 736 <span type="species:ncbi:9606">human</span>
###xml 767 772 <span type="species:ncbi:9606">human</span>
###xml 824 829 <span type="species:ncbi:9606">Human</span>
###xml 1014 1019 <span type="species:ncbi:9606">human</span>
###xml 1095 1099 <span type="species:ncbi:9615">dogs</span>
###xml 1242 1246 <span type="species:ncbi:9615">dogs</span>
###xml 1358 1363 <span type="species:ncbi:9606">human</span>
###xml 1471 1476 <span type="species:ncbi:9940">sheep</span>
###xml 1697 1701 <span type="species:ncbi:9615">dogs</span>
###xml 1711 1715 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1867 1871 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 2072 2077 <span type="species:ncbi:9606">human</span>
###xml 2185 2189 <span type="species:ncbi:9615">dogs</span>
Neuronal ceroid lipofuscinoses (NCL) represents a group of heritable neurodegenerative storage diseases in man, mice, and several domestic animals like cattle, sheep, goat, cat, and certain dog breeds [1]. NCL diseases are characterized by the accumulation of autofluorescent cytoplasmic storage bodies in cells of the brain and retina. NCL diseases cause neurological symptoms that progress relentlessly and culminate in a vegetative state in humans and premature death [2]. Canine late-onset NCL variants primarily affect Tibetan Terrier and Polish Owczarek Nizinny (PON) dogs. A monogenic autosomal recessive mode of transmission was suggested for those breeds [3,4]. NCL-affected dogs represent valuable animal models to study human late-onset NCL variants since human families segregating for adult NCL are infrequent. Human NCL is a genetically heterogeneous disease with six identified disease genes (PPT1, TPP1, CLN3, CLN5, CLN6 and CLN8) [5]. Causal mutations within the canine orthologs of the six known human NCL genes have not been identified in NCL-affected Tibetan Terrier and PON dogs [6-9]. Single point mutations in the coding regions of the canine CLN8 and CLN5 genes were found in affected English Setter and Border collie dogs, respectively, showing juvenile NCL [6,10]. There are still undiscovered loci causing NCL beside the six known human genes, as indicated by findings in NCL-affected domestic and laboratory animals. In White Swedish Landrace sheep a CTSD mutation was reported and a mutation within the ortholog canine CTSD gene was detected in NCL-affected American Bulldogs [11]. Recently, CTSD was excluded as candidate gene in NCL-affected Tibetan Terrier and PON dogs [12]. In mice the chloride channel 3 gene (Clcn3) encoding an intracellular chloride channel was described to cause a phenotype similar to NCL [13]. Clcn3-deficient mice are characterized by developmental retardation and higher mortality combined with neurological manifestations such as blindness, motor coordination deficit, and spontaneous hyperlocomotion similar to human and canine NCL. To evaluate whether the CLCN3 gene is involved in the NCL-affected Tibetan Terrier and PON dogs, we determined the full-length cDNA sequence, characterized the gene structure, and analyzed the coding sequence of the canine ortholog.
###end p 9
###begin title 10
Results and discussion
###end title 10
###begin title 11
Sequence analysis
###end title 11
###begin p 12
###xml 150 156 150 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 219 225 219 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 240 246 240 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 488 494 488 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 560 566 560 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 591 592 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 636 642 636 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 930 931 930 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 953 959 953 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 1086 1092 1086 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 630 635 <span type="species:ncbi:9606">human</span>
###xml 672 675 <span type="species:ncbi:9615">dog</span>
###xml 937 940 <span type="species:ncbi:9615">dog</span>
RT-PCR from canine lung mRNA amplified two splice variants, which were verified by direct DNA-sequencing of the RT-PCR products. Similar to the human CLCN3 sequence the alternative usage of exon 12 produces the shorter CLCN3 and the longer CLCN3 isoform e, respectively (Figure 1). Overlapping canine cDNA fragments containing all junctions between the exons were generated by RT-PCR, sequenced, and used for comparison with the genomic sequence. These analyses indicated that the canine CLCN3 gene consists of 13 exons separated by twelve introns. The canine CLCN3 gene spans 52 kb (Figure 1) compared to 14 exons over 100 kb in human CLCN3 (NCBI build 35.1)) because in dog no untranslated 5'-exon is used. All splice donor/splice acceptor sites conform to the GT/AG rule. The experimentally verified existence of the two alternative splice variants is in agreement with the initially identified canine 5'-EST sequences (Figure 1). In dog the shorter CLCN3 transcript [EMBL:AM048629] contains an open reading frame of 2,376 bp encoding a protein of 791 amino acids. The longer canine CLCN3 isoform e transcript [EMBL:AM048628] contains an open reading frame of 2,517 bp encoding a sequence of 838 amino acids.
###end p 12
###begin p 13
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genomic structure of the canine <italic>CLCN3 </italic>gene</bold>
Genomic structure of the canine CLCN3 gene. Translated exons are shown as solid boxes, untranslated regions of exons as shaded boxes. The two alternative gene transcripts are shown below.
###end p 13
###begin title 14
Mutation analysis
###end title 14
###begin p 15
###xml 44 45 44 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 427 433 427 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 541 542 541 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 74 78 <span type="species:ncbi:9615">dogs</span>
###xml 138 141 <span type="species:ncbi:9615">dog</span>
###xml 458 461 <span type="species:ncbi:9615">dog</span>
A total of 13 sequence polymorphisms (Table 1) were found in the examined dogs as compared to the CLCN3 reference sequence of the current dog genome assembly (boxer genome assembly 1.1). The codon in exon 2 with the A/G transition codes for glycine in both SNP variants and the codon in exon 9 with the A/G transition codes for proline in both SNP variants. None of the 11 intronic polymorphisms did affect splice sites in the CLCN3 gene. For the single PON dog there were seven polymorphisms compared to the Boxer reference sequence (Table 1).
###end p 15
###begin p 16
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
Polymorphisms and observed haplotypes in the canine CLCN3 gene
###end p 16
###begin p 17
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1 </sup>
1 Numbering refers to the position of the polymorphic nucleotide within the given exon or intron respectively.
###end p 17
###begin p 18
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 46 49 <span type="species:ncbi:9615">dog</span>
2 Nucleotide refers to the publicly available dog genome sequence (AAEX01020012) from the boxer named Tasha.
###end p 18
###begin p 19
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 152 156 <span type="species:ncbi:9615">dogs</span>
###xml 237 241 <span type="species:ncbi:9615">dogs</span>
###xml 358 361 <span type="species:ncbi:9615">dog</span>
###xml 599 603 <span type="species:ncbi:9615">dogs</span>
###xml 718 722 <span type="species:ncbi:9615">dogs</span>
Assuming linkage disequilibrium between the polymorphic loci six different haplotypes could be constructed for the SNP genotypes in the Tibetan Terrier dogs (Table 1). Four out of six haplotypes occurred in both, affected and unaffected dogs, respectively (Table 2). Only the haplotypes 3 and 4 occurred in a single heterozygous NCL-affected Tibetan Terrier dog (Table 2). Due to the assumption of a single recessive founder mutation within this breed we expect homozygosity in affected individuals. Table 2 summarizes the haplotype distribution among the NCL-affected and the clinical unsuspicious dogs. The chi-square statistic for testing these haplotypes for association with disease status in the Tibetan Terrier dogs was calculated as 5.5786 with degree of freedom 1, which had a p-value of 0.80, indicating no significant association.
###end p 19
###begin p 20
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 44 48 <span type="species:ncbi:9615">dogs</span>
CLCN3 genotypes in NCL-affected and control dogs
###end p 20
###begin p 21
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1 </sup>
1 Genotypes correspond to the deduced haplotypes shown in Table 1.
###end p 21
###begin title 22
Conclusion
###end title 22
###begin p 23
###xml 114 120 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 237 243 237 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 183 187 <span type="species:ncbi:9615">dogs</span>
###xml 339 343 <span type="species:ncbi:9615">dogs</span>
###xml 437 441 <span type="species:ncbi:9615">dogs</span>
The presented data indicate that the detected polymorphisms in the coding and adjacent intronic regions of canine CLCN3 can be excluded as disease harboring mutations in the examined dogs. Therefore it seems to be likely that the entire CLCN3 can be excluded as a candidate gene for the late-onset NCL phenotype in Tibetan Terrier and PON dogs. As the candidate gene approach did not reveal the causative gene in Tibetan Terrier and PON dogs it might be indicated to perform a genome wide linkage scan using NCL segregating families to map the canine chromosome region harboring the deleterious gene.
###end p 23
###begin title 24
Methods
###end title 24
###begin title 25
Sequence analysis
###end title 25
###begin p 26
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 533 539 533 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 1206 1207 1206 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1305 1311 1305 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 1602 1603 1602 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1862 1868 1862 1868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 1888 1894 1888 1894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 2032 2034 2032 2034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 104 107 <span type="species:ncbi:9615">dog</span>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 323 326 <span type="species:ncbi:9615">dog</span>
###xml 1856 1861 <span type="species:ncbi:9606">human</span>
The human reference CLCN3 mRNA [GenBank:] was used as query in cross-species BLAST searches against the dog genome assembly (Boxer genome assembly 1.1). A single canine genomic contig of 577,638 bp was isolated [GenBank:]. The human mRNA sequence was used to identify putative exons in the canine genomic sequence used for dog specific RACE primer design. Total RNA from lung tissue of a normal female Beagle (Biocat, Heidelberg, Germany) was used for amplification of RACE PCR products. Isolation of full length cDNA for the canine CLCN3 gene was achieved by a modified rapid amplification of cDNA ends (RACE) protocol with the FirstChoiceTM RNA ligase-mediated (RLM)-RACE kit (Ambion Europe, Huntingdon, UK). Briefly, in RLM-RACE uncapped RNAs were dephosphorylated before the cap of full-length messenger RNAs (mRNAs) was removed enzymatically. After this step an RNA oligonucleotide adaptor was ligated to the 5'-end of the decapped mRNAs. As only full-length RNAs carried a 5'-phosphate group, the adaptor was expected to ligate exclusively to full-length mRNAs, while the dephosphorylated other RNAs were not able to undergo a ligation reaction. RT-PCR using two pairs of nested gene-specific (Table 3) and adaptor-specific primer pairs (Ambion) were then used to amplify the complete 5'-end of the CLCN3 cDNA according to the instructions of the manufacturer. Similarly, the 3'-end was amplified using two pairs of nested gene-specific and 3'-adaptor-specific primers. 5'- and 3'-RACE products and an additional 1885 bp RT-PCR product using sense and antisense primers from exon 1 and 10 (Table 3) were cloned into pDrive plasmid vectors using the Qiagen PCR cloning kit (Qiagen, Hilden, Germany) and several clones were sequenced. The obtained canine cDNA sequences were aligned with partially overlapping canine EST sequences corresponding to the human CLCN3 [GenBank:,,,,], and CLCN3 isoform e [GenBank:], respectively. The exact canine genomic structure was determined using the mRNA-to-genomic alignment program Spidey [14].
###end p 26
###begin p 27
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
Primer sequences for the amplification of canine CLCN3 cDNA
###end p 27
###begin title 28
Mutation analysis
###end title 28
###begin p 29
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 518 524 518 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 56 59 <span type="species:ncbi:9615">dog</span>
###xml 104 108 <span type="species:ncbi:9615">dogs</span>
###xml 168 172 <span type="species:ncbi:9615">dogs</span>
###xml 277 280 <span type="species:ncbi:9615">dog</span>
Genomic DNA was isolated from a single NCL-affected PON dog, six unrelated NCL-affected Tibetan Terrier dogs, and eight unrelated clinical unsuspicious Tibetan Terrier dogs (> 8 years old). Clinical neurologic, behavioral, and ophthalmologic evaluations were performed on each dog by a single external consultant veterinarian [4,15]. The phenotypes of the affected animals have been confirmed by detection of autofluorescent cytoplasmic inclusions within neurons throughout the retina and brain after necropsy. The 13 CLCN3 exons with flanking sequences were PCR amplified and directly sequenced with the DYEnamic ET Terminator kit (Amersham Biosciences, Freiburg, Germany) and a MegaBACE 1000 capillary sequencer (Amersham Biosciences), using PCR primers listed in table 4 as sequencing primers. The association analysis for this paper was generated using SAS/HAPLOTYPE software, Version 2.1.39 of the SAS System for Windows (2003 SAS Institute Inc., Cary, NC, USA).
###end p 29
###begin p 30
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLCN3 </italic>
Primer sequences for the amplification of canine CLCN3 exons
###end p 30
###begin title 31
Authors' contributions
###end title 31
###begin p 32
AW did the mutation screen and drafted parts of the manuscript. OD proposed the idea and was responsible for funding. CD performed the RACE experiments, analyzed the sequence data, and performed manuscript editing.
###end p 32
###begin title 33
Acknowledgements
###end title 33
###begin p 34
We thank Dr. med. vet. R. Brahm, Dortmund, Germany, for clinical examination and Dr. med. vet. K. Matiasek, Institute of Veterinary Pathology LMU Munich, Germany, for neuropathology.
###end p 34
###begin article-title 35
Lysosomal storage diseases of animals: an essay in comparative pathology
###end article-title 35
###begin article-title 36
###xml 56 61 <span type="species:ncbi:9606">human</span>
Current state of clinical and morphological features in human NCL
###end article-title 36
###begin article-title 37
Tibetan terrier model of canine ceroid lipofuscinosis
###end article-title 37
###begin article-title 38
###xml 68 71 <span type="species:ncbi:9615">dog</span>
Neuronal ceroid lipofuscinosis in the Polish Owczarek Nizinny (PON) dog. A retinal study
###end article-title 38
###begin article-title 39
###xml 24 29 <span type="species:ncbi:9606">human</span>
The genetic spectrum of human neuronal ceroid-lipofuscinoses
###end article-title 39
###begin article-title 40
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN8 </italic>
###xml 46 50 <span type="species:ncbi:9615">dogs</span>
A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis
###end article-title 40
###begin article-title 41
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TPP1 </italic>
###xml 132 136 <span type="species:ncbi:9615">dogs</span>
Evaluation of the canine TPP1 gene as a candidate for neuronal ceroid lipofuscinosis in Tibetan Terrier and Polish Owczarek Nizinny dogs
###end article-title 41
###begin article-title 42
###xml 74 77 <span type="species:ncbi:9615">dog</span>
Characterization of candidate genes for neuronal ceroid lipofuscinosis in dog
###end article-title 42
###begin article-title 43
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN3 </italic>
###xml 161 165 <span type="species:ncbi:9615">dogs</span>
Coding sequence and exon/intron organization of the canine CLN3 (Batten disease) gene and its exclusion as the locus for ceroid-lipofuscinosis in English setter dogs
###end article-title 43
###begin article-title 44
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN5 </italic>
###xml 81 85 <span type="species:ncbi:9615">dogs</span>
A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs
###end article-title 44
###begin article-title 45
A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis
###end article-title 45
###begin article-title 46
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTSD </italic>
The canine CTSD gene as a candidate for late-onset neuronal ceroid lipofuscinosis
###end article-title 46
###begin article-title 47
###xml 48 53 <span type="species:ncbi:9606">human</span>
CLC-3 deficiency leads to phenotypes similar to human neuronal ceroid lipofuscinosis
###end article-title 47
###begin article-title 48
Spidey
###end article-title 48
###begin article-title 49
Assessment of retinal function and characterization of lysosomal storage body accumulation in the retinas and brains of Tibetan Terriers with ceroid-lipofuscinosis
###end article-title 49

